Ravi Shridhar is an Oncology physician affiliated with Florida Hospital Cancer Institute. OpenAlex indexes 306 publications with 5,454 citations (h-index 39); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
601 E Rollins St
Radiation Oncology
Orlando, FL 328031248
Telephone
407-303-5857Registry record last updated 9 Oct 2014.
Clinical trials
- GTX-RT in Borderline Resectable Pancreatic Cancer
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
- Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- HISTOSONICS, INC.Program year20253 payments$10,149openpaymentsdata.cms.gov ↗
- Delcath SystemsProgram year20256 payments
- Telix PharmaceuticalsProgram year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
45.7%Corticosteroid20.1%Prednisone100%Part D≥54 patientsAluminum Complex13.4%Sucralfate100%Part D≥28 patients+ 2 more classes in this area
Dermatology
19.2%Corticosteroid15.7%Methylprednisolone100%Part D≥46 patientsSulfonamide Antibacterial3.5%Ssd100%Part D≥11 patientsNervous system
18.8%Opioid Agonist18.8%Fentanyl39%Oxycodone Hcl31%Oxycodone-Acetaminophen31%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparative Perioperative Outcomes by Esophagectomy Surgical Technique
Journal of Gastrointestinal Surgery
2019 - Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study
Journal of Vascular and Interventional Radiology
2018 - The accuracy of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as a marker for gastrointestinal malignancies
Journal of Gastrointestinal Oncology
2018 - Outcomes associated with robotic approach to pancreatic resections
Journal of Gastrointestinal Oncology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Herbert Newton, MD
Florida Hospital Cancer Institute
Nathalie McKenzie, MD
Florida Hospital Cancer Institute
Rajesh Sehgal, MD
Florida Hospital Cancer Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”